CD59 and neoplasm: The ICT-CMC-CD59sp microspheres constructed in this experiment can bind CD59sp specifically to the tumor cell CD59 to guide the drug to the surface of oral squamous cancer cells, intake Epanin inside the cells, activate the complement to form MAC and lyse OSCC tumor cells.